Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183144 · ClinicalTrials.gov registry record · Phase 2
A Therapeutic Workplace for Alcohol Dependence
A Phase 2 study of Alcohol Dependence, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT00183144: Completed Phase 2 study of Alcohol Dependence, sponsored by Johns Hopkins University.
NCT00183144 is a Phase 2 study of Alcohol Dependence that has completed, run by Johns Hopkins University. The registered enrollment target is 156 participants, below the 310-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183144, a Phase 2 study of Alcohol Dependence, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the Therapeutic Workplace is effective in increasing and maintaining long-term drug abstinence in homeless, alcohol dependent adults.
Conditions Studied
Interventions
- BEHAVIORAL Contingency management
Study Locations (1)
Maryland
- Center for Learning and Health, Johns Hopkins Bayview Medical Campus, 5200 Eastern Ave., Suite W142 - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2001-11 |
| Est. Completion | 2006-04 |
| Phase | Phase 2 |
What the finished NCT00183144 record still lists
NCT00183144 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 310-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Alcohol Dependence appearing as the primary indexed condition, and to 1 intervention - of which Contingency management is the first listed.
NCT00183144 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00183144 about?
NCT00183144 is a clinical study titled "A Therapeutic Workplace for Alcohol Dependence". The purpose of this study is to determine whether the Therapeutic Workplace is effective in increasing and maintaining long-term drug abstinence in homeless, alcohol dependent adults.
What is the current status of trial NCT00183144?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2001-11. Estimated completion is 2006-04.
What conditions does trial NCT00183144 study?
This clinical trial studies the following conditions: Alcohol Dependence.
What interventions are being tested in trial NCT00183144?
The interventions under investigation include: Contingency management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00183144?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00183144 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00183144's enrollment target sits among peer trials
156 12th of 43 higher than 32 of 43 other Alcohol Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
Gabapentin Treatment of Alcohol Dependence
COMPLETED · Phase 2
-
The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)
COMPLETED · Phase 2
-
Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence
COMPLETED · Phase 2
-
Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence
COMPLETED · Phase 2
-
A Study in the Treatment of Alcohol Dependence.
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia